Sven Mahner

8.0k total citations · 2 hit papers
140 papers, 2.8k citations indexed

About

Sven Mahner is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sven Mahner has authored 140 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 42 papers in Molecular Biology and 25 papers in Immunology. Recurrent topics in Sven Mahner's work include Ovarian cancer diagnosis and treatment (19 papers), Cancer Cells and Metastasis (14 papers) and Reproductive System and Pregnancy (14 papers). Sven Mahner is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Cancer Cells and Metastasis (14 papers) and Reproductive System and Pregnancy (14 papers). Sven Mahner collaborates with scholars based in Germany, France and United States. Sven Mahner's co-authors include Udo Jeschke, Christina Kühn, Nadia Harbeck, Yuichi Sugiyama, Wolfgang Stremmel, Daniel Rost, Michael Friedländer, Linn Woelber, Doris Mayr and Amit M. Oza and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sven Mahner

134 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

2014 426 citations Amit M. Oza, David Cibula et al. profile →
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023

2023 85 citations Maaike H.M. Oonk, François Planchamp et al. International Journal of Gynecological Cancer profile →

Peers

Countries citing papers authored by Sven Mahner

Since Specialization

Citations

This map shows the geographic impact of Sven Mahner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Mahner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Mahner more than expected).

Fields of papers citing papers by Sven Mahner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Mahner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Mahner. The network helps show where Sven Mahner may publish in the future.

Co-authorship network of co-authors of Sven Mahner

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Mahner. A scholar is included among the top collaborators of Sven Mahner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Mahner. Sven Mahner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CCL22 as an independent prognostic factor in endometrial cancer patients 2024 ·Translational Oncology ·(unknown), Thomas Kolben, Carolin Perleberg, Sarah Meister, (unknown), (unknown), Elisa Schmoeckel, Sven Mahner, Stefanie Corradini, Fabian Trillsch, Mirjana Kessler, Udo Jeschke, Susanne Beyer	1
2	Akzeptanz- und Nutzerfreundlichkeitsanalyse der elektronischen Patient Reported Outcomes (ePRO)-Erhebung bzgl. der gesundheitsbezogenen Lebensqualität (HRQoL) von Endometriosepatientinnen mittels der Onlineanwendung Cankado 2024 ·Geburtshilfe und Frauenheilkunde ·Michael Jäger, (unknown), Stefan Meister, Sebastian E. Beyer, (unknown), (unknown), Sven Mahner, (unknown), T Kolben	0
3	Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative 2024 ·European Journal of Oncology Nursing ·(unknown), (unknown), Kerstin Paradies, (unknown), Timo Schinköthe, Renate Haidinger, Ronald Kates, Dirk Hempel, Sven Mahner, Bernd Kost, Alexander Köenig, (unknown), Fabian Trillsch, Sebastian Theurich, Nadia Harbeck, Valeria Milani, Rachel Wuerstlein	0
4	RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro 2023 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Elisa Schmoeckel, (unknown), (unknown), Sven Mahner, Doris Mayr, Artur Mayerhofer, Udo Jeschke, Aurelia Vattai	8
5	Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative 2022 ·International Journal of Gynecological Cancer ·Martina Aida Ángeles, Félix Boria, (unknown), Nicolò Bizzarri, (unknown), (unknown), Joanna Kacperczyk‐Bartnik, (unknown), (unknown), Sven Mahner, Murat Gültekin, David Cibula, Alexandros Rodolakis, Domenica Lorusso, Mansoor Raza Mirza, Anna Fagotti, Jonathan A. Ledermann, Christina Fotopoulou, Pedro T. Ramírez	2
6	Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects 2022 ·Cancer Research Communications ·Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, B.J. Rimel, Jørn Herrstedt, Amit M. Oza, Ulrich Canzler, Jonathan S. Berek, Antonio González-Martı́n, (unknown), Rosemary Lord, Masoud Azodi, (unknown), Zebin Wang, Yong Li, Divya Gupta, Ursula A. Matulonis, Bin Feng	5
7	Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report 2022 ·Journal of Medical Case Reports ·(unknown), Marija Petković, Alexander König, Julian Koch, (unknown), Rachel Wuerstlein, Nadia Harbeck, Sven Mahner, Till Kaltofen	1
8	Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells 2022 ·Cellular Oncology ·Thomas Kolben, (unknown), Carolin Perleberg, (unknown), David Anz, (unknown), Sarah Meister, Elisa Schmoeckel, Alexander Burges, Bastian Czogalla, Anna Hester, Sven Mahner, Mirjana Kessler, Udo Jeschke, Stefanie Corradini, Fabian Trillsch, Susanne Beyer	11
9	The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients 2022 ·Journal of Reproductive Immunology ·(unknown), Aurelia Vattai, Christina Kühn, (unknown), (unknown), Achim Wöckel, Elisa Schmoeckel, Sven Mahner, Udo Jeschke	8
10	Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany 2021 ·Archives of Gynecology and Obstetrics ·Till Kaltofen, (unknown), Nadia Harbeck, Rachel Wuerstlein, (unknown), Alexander Burges, Sven Mahner, Fabian Trillsch	14
11	Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl Offspring 2021 ·International Journal of Molecular Sciences ·(unknown), Zhi Ma, Lin Peng, Christina Kühn, Martina Rahmeh, Sven Mahner, Udo Jeschke, Viktoria von Schönfeldt	12
12	Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions 2021 ·International Journal of Molecular Sciences ·Peng Lin, (unknown), Ye Yao, Zhi Ma, Christina Kühn, Martina Rahmeh, Sven Mahner, Antonis Makrigiannakis, Udo Jeschke, Viktoria von Schönfeldt	30
13	COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective 2021 ·The Breast ·(unknown), Rachel Wuerstlein, Alexander Köenig, (unknown), Susanne Beyer, Till Kaltofen, Tom Degenhardt, Alexander Burges, Fabian Trillsch, Sven Mahner, Nadia Harbeck, Anca Chelariu-Raicu	21
14	Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer 2021 ·Cancers ·(unknown), (unknown), Vincent Cavaillès, Sophie Sixou, Till Kaltofen, (unknown), Helene Hildegard Heidegger, Nina Ditsch, Sven Mahner, Udo Jeschke, Theresa� Vilsmaier	6
15	The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Aurelia Vattai, Till Kaltofen, (unknown), (unknown), Jan‐Niclas Mumm, Helene Hildegard Heidegger, Nina Ditsch, Sven Mahner, Udo Jeschke, Theresa� Vilsmaier	14
16	Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage 2021 ·International Journal of Molecular Sciences ·(unknown), Anca Chelariu-Raicu, Ye Yao, Zhi Ma, (unknown), Hellen Ishikawa‐Ankerhold, Martina Rahmeh, Sven Mahner, Udo Jeschke, Viktoria von Schönfeldt	8
17	L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of Gi- Protein- Coupled Receptors 2020 ·International Journal of Molecular Sciences ·(unknown), Christina Kühn, Till Kaltofen, Theresa� Vilsmaier, Doris Mayr, Sven Mahner, Nina Ditsch, Udo Jeschke, Aurelia Vattai	7
18	Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers 2020 ·Journal of Translational Medicine ·(unknown), Christina Kühn, Doris Mayr, Nina Ditsch, (unknown), (unknown), Nadia Harbeck, Sven Mahner, Udo Jeschke, Vincent Cavaillès, Sophie Sixou	20
19	European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer 2017 ·International Journal of Gynecological Cancer ·Maaike H.M. Oonk, François Planchamp, Peter Baldwin, Mariusz Bidziński, Mats Brännström, Fabio Landoni, Sven Mahner, Umesh Mahantshetty, Mansoor Raza Mirza, Cordula Petersen, Denis Querleu, Sigrid Regauer, Lukáš Rob, Roman Rouzier, Е. A. Ulrikh, Jacobus van der Velden, Ignace Vergote, Linn Woelber, Ate G.J. van der Zee	133
20	Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer 2016 ·Thrombosis Research ·(unknown), (unknown), Susanne Lezius, Ali Amirkhosravi, Mónica Dávila, John L. Francis, Yohei Hisada, Nigel Mackman, Carsten Bokemeyer, Barbara Schmalfeldt, Sven Mahner, Florian Länger	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact